13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001009258
Total reported value
$9.6B
$9.6B
367 檔
23.6%
The Q1 2024 SEC filing reveals that Deerfield Management Company, L.p. held a total portfolio value of $9.6B, covering 367 public equity positions.
In Q1 2024, Deerfield Management Company, L.p. displayed an active expansion posture, initiating 17 new positions and adding to 13 existing holdings, outstripping position reductions.
In terms of portfolio concentration, the top 5 core holdings (including NUVL, VTRS, CNC) accounted for 23.6% of total reported equity market value during Q1 2024.
Top New Position Initiated
IART 0.5 08-15-25
市值: $98.7M
Top Position Liquidated / Trimmed
GKOS 2.75 06-15-27
前期市值: $414.9M
Showing top 200 holdings (of 367 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NUVL | Nuvalent Inc-a | Stock-Other | 26.12% | +1.37% | — | |
| 2 | VTRS | Viatris Inc | Stock-Healthcare | 4.44% | +0.13% | +7.71% | |
| 3 | CNC | Centene CORP | Stock-Healthcare | 3.25% | +0.99% | +19.54% | |
| 4 | LRMR | Larimar Therapeutics Inc | Stock-Other | 2.80% | -0.76% | +25.33% | |
| 5 | BKD 2 10-15-26Bond | Brookdale Senior Living | Bond | 2.76% | — | +10.93% | |
| 6 | AHCO | Adapthealth CORP | Stock-Other | 2.65% | -0.36% | -2.57% | |
| 7 | CPRX | Catalyst Pharmaceuticals Inc | Stock-Healthcare | 2.53% | -1.15% | EXIT | |
| 8 | OSCR | Oscar Health Inc - Class A | Stock-Healthcare | 2.42% | — | -16.66% | |
| 9 | ✓ | Fusion Pharmaceuticals Inc | Stock-Other | 2.37% | — | — | |
| 10 | ACH | Accendra Health Inc | Stock-Other | 2.35% | — | -6.73% | |
| 11 | INSM 1.75 01-15-25Bond | Insmed Inc | Bond | 2.16% | — | — | |
| 12 | ✓ | Merus N V | Stock-Other | 2.08% | — | -12.27% | |
| 13 | ACCD 0.5 04-01-26Bond | Accolade Inc | Bond | 2.04% | — | — | |
| 14 | KURA | Kura Oncology Inc | Stock-Other | 2.01% | — | +1.86% | |
| 15 | IDYA | Ideaya Biosciences Inc | Stock-Other | 2.01% | +0.46% | — | |
| 16 | SPRY | Ars Pharmaceuticals Inc | Stock-Other | 1.97% | -0.08% | — | |
| 17 | BKD | Brookdale Senior Living Inc | Stock-Other | 1.80% | +0.07% | +5.54% | |
| 18 | RVMD | Revolution Medicines Inc | Stock-Healthcare | 1.73% | +2.03% | — | |
| 19 | IART 0.5 08-15-25Bond | Integra Lifesciences Hld | Bond | 1.72% | — | — | |
| 20 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 1.66% | -0.95% | EXIT | |
| 21 | SGRY | Surgery Partners Inc | Stock-Other | 1.65% | — | +51.36% | |
| 22 | DCPHEUR | Deciphera Pharmaceuticals In | Stock-Other | 1.40% | — | -11.42% | |
| 23 | ✓ | Hillevax Inc | Stock-Other | 1.16% | — | — | |
| 24 | SWTXUSD | Springworks Therapeutics Inc | Stock-Other | 1.10% | — | -50.35% | |
| 25 | EHABUSD | Enhabit Inc | Stock-Other | 1.01% | -0.79% | EXIT | |
| 26 | NKTX | Nkarta Inc | Stock-Other | 0.98% | — | +52.77% | |
| 27 | BIO | Bio-rad Laboratories-a | Stock-Healthcare | 0.92% | -0.05% | +0.53% | |
| 28 | BNTX | Biontech Se-adr | Stock-Other | 0.91% | — | — | |
| 29 | EWTX | Edgewise Therapeutics Inc | Stock-Other | 0.91% | — | -26.91% | |
| 30 | IART | Integra Lifesciences Holding | Stock-Other | 0.91% | — | +30.48% | |
| 31 | LKFT | Lakefront Biotherapeutic-adr | Stock-Other | 0.79% | — | +126.81% | |
| 32 | GPCR | Structure Therapeutics Inc | Stock-Other | 0.77% | +0.17% | +25.63% | |
| 33 | IRON | Disc Medicine Inc | Stock-Other | 0.72% | — | +43.34% | |
| 34 | ALHC | Alignment Healthcare Inc | Stock-Other | 0.71% | — | +137.06% | |
| 35 | VKTX | Viking Therapeutics Inc | Stock-Healthcare | 0.66% | — | -63.76% | |
| 36 | KYTX | Kyverna Therapeutics Inc | Stock-Other | 0.63% | -0.01% | — | |
| 37 | EMBC | Embecta CORP | Stock-Healthcare | 0.63% | -0.17% | +96.86% | |
| 38 | ISREUR | Isoray Inc | Stock-Other | 0.58% | — | — | |
| 39 | SLDB | Solid Biosciences Inc | Stock-Other | 0.52% | — | — | |
| 40 | DAWNGBX | Day One Biopharmaceuticals I | Stock-Other | 0.51% | -0.94% | EXIT | |
| 41 | LNTH 2.625 12-15-27Bond | Lantheus Holdings Inc | Bond | 0.49% | — | — | |
| 42 | CNMD | Conmed CORP | Stock-Other | 0.47% | — | +13130.24% | |
| 43 | BCRX | Biocryst Pharmaceuticals Inc | Stock-Other | 0.44% | -0.12% | +10.03% | |
| 44 | INMD | InMode Ltd. | Stock-Other | 0.44% | — | — | |
| 45 | ACCDUSD | Accolade Inc | Stock-Other | 0.43% | — | — | |
| 46 | PHVS | Pharvaris N.V. | Stock-Other | 0.43% | +0.18% | +30.70% | |
| 47 | AUTL | Autolus Therapeutics PLC | Stock-Other | 0.40% | — | — | |
| 48 | APGE | Apogee Therapeutics Inc | Stock-Other | 0.38% | — | — | |
| 49 | CABA | Cabaletta Bio Inc | Stock-Other | 0.37% | — | -37.31% | |
| 50 | DCGO | Docgo Inc | Stock-Other | 0.36% | — | -4.06% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | IART 0.5 08-15-25Bond | Integra Lifesciences Hld | +1.7% | NEW | New buy |
| 2 | LRMR | Larimar Therapeutics Inc | +1.4% | +25.33% | Add |
| 3 | ✓ | Fusion Pharmaceuticals Inc | +1.2% | — | Unchanged |
| 4 | BNTX | Biontech Se-adr | +0.9% | NEW | New buy |
| 5 | SPRY | Ars Pharmaceuticals Inc | +0.9% | — | Unchanged |
| 6 | AHCO | Adapthealth CORP | +0.8% | -2.57% | Trim |
| 7 | KYTX | Kyverna Therapeutics Inc | +0.6% | NEW | New buy |
| 8 | KURA | Kura Oncology Inc | +0.6% | +1.86% | Add |
| 9 | ISREUR | Isoray Inc | +0.6% | NEW | New buy |
| 10 | NKTX | Nkarta Inc | +0.6% | +52.77% | Add |
| 11 | ✓ | Merus N V | +0.6% | -12.27% | Trim |
| 12 | CNC | Centene CORP | +0.5% | +19.54% | Add |
| 13 | OSCR | Oscar Health Inc - Class A | +0.5% | -16.66% | Trim |
| 14 | SLDB | Solid Biosciences Inc | +0.5% | NEW | New buy |
| 15 | ACH | Accendra Health Inc | +0.5% | -6.73% | Trim |
| 16 | LNTH 2.625 12-15-27Bond | Lantheus Holdings Inc | +0.5% | NEW | New buy |
| 17 | VTRS | Viatris Inc | +0.5% | +7.71% | Add |
| 18 | CNMD | Conmed CORP | +0.5% | +13130.24% | Add |
| 19 | INMD | InMode Ltd. | +0.4% | NEW | New buy |
| 20 | ACCDUSD | Accolade Inc | +0.4% | NEW | New buy |
| 21 | SGRY | Surgery Partners Inc | +0.4% | +51.36% | Add |
| 22 | AUTL | Autolus Therapeutics PLC | +0.4% | NEW | New buy |
| 23 | APGE | Apogee Therapeutics Inc | +0.4% | NEW | New buy |
| 24 | VTYXUSD | Ventyx Biosciences Inc | +0.3% | NEW | New buy |
| 25 | CGEM | Cullinan Therapeutics Inc | +0.3% | NEW | New buy |
| 26 | LKFT | Lakefront Biotherapeutic-adr | +0.3% | +126.81% | Add |
| 27 | BKD 2 10-15-26Bond | Brookdale Senior Living | +0.3% | +10.93% | Add |
| 28 | IDYA | Ideaya Biosciences Inc | +0.3% | — | Unchanged |
| 29 | FATE | Fate Therapeutics Inc | +0.3% | NEW | New buy |
| 30 | NAMS | NewAmsterdam Pharma Company N.V. | +0.3% | NEW | New buy |
| 31 | LNTH | Lantheus Holdings Inc | +0.3% | NEW | New buy |
| 32 | ✓ | Engene Holdings Inc | +0.2% | NEW | New buy |
| 33 | IRON | Disc Medicine Inc | +0.2% | +43.34% | Add |
| 34 | VKTX | Viking Therapeutics Inc | +0.2% | -63.76% | Trim |
| 35 | BKD | Brookdale Senior Living Inc | +0.2% | +5.54% | Add |
| 36 | EYPT | Eyepoint Inc | +0.2% | NEW | New buy |
| 37 | ALHC | Alignment Healthcare Inc | +0.2% | +137.06% | Add |
| 38 | GPCR | Structure Therapeutics Inc | +0.2% | +25.63% | Add |
| 39 | RVMD | Revolution Medicines Inc | +0.1% | — | Unchanged |
| 40 | DCPHEUR | Deciphera Pharmaceuticals In | -0.3% | -11.42% | Trim |
| 41 | PODD | Insulet CORP | -0.4% | -38.49% | Trim |
| 42 | CABA | Cabaletta Bio Inc | -0.5% | -37.31% | Trim |
| 43 | NBIX | Neurocrine Biosciences Inc | -0.5% | -22.94% | Trim |
| 44 | SWTXUSD | Springworks Therapeutics Inc | -0.6% | -50.35% | Trim |
| 45 | BAX | Baxter International Inc | -1% | -99.55% | Trim |
| 46 | NUVL | Nuvalent Inc-a | -1% | — | Unchanged |
| 47 | ✓ | Rayzebio Inc | -1.2% | EXIT | Sold out |
| 48 | NTRA 2.25 05-01-27Bond | Natera Inc | -3.2% | EXIT | Sold out |
| 49 | NVTA 4.5 03-15-28 ABond | Invitae CORP | -3.5% | EXIT | Sold out |
| 50 | GKOS 2.75 06-15-27Bond | Glaukos CORP | -7.7% | EXIT | Sold out |
According to official SEC Form 13F filings, Deerfield Management Company, L.p. reported a total U.S. public equity portfolio value of $9.6B across 367 disclosed positions in Q1 2024.
During Q1 2024, Deerfield Management Company, L.p.'s top holdings by market value included NUVL (26.1%)、VTRS (4.4%)、CNC (3.3%). The largest single position, NUVL, represented 26.1% of total portfolio value.
In Q1 2024, Deerfield Management Company, L.p. made 45 total portfolio adjustments, initiating 17 new buys, adding to 13 positions, trimming 11 holdings, and fully liquidating 4 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.